- Overview 1 Intro 0:00:00 2 Forward Looking Statements 0:00:33 3 Overview 0:01:30 4 Business Verticals 0:08:43 5 Track Record 0:09:23
- Pharmaloz Manufacturing 6 Manufacturing Facility 0:11:05 7 Strategic Initiatives 0:13:32
- ProPhase BioPharma 8 Esophageal Cancer 0:15:40 9 Total Addressable Market 0:16:34 10 BE-Smart Advantages 0:23:50
- DNA Complete 11 Launched October 2024 0:26:12 12 Overview 0:26:37 13 DNA Expand 0:27:09
- Nebula Genomics 14 Assets 0:29:11
- ProPhase Supplements 15 Dietary Supplements 0:29:33 16 Equivir 0:30:55 17 Clinical Trial 0:34:36 18 Timeline 0:34:39
- Summary 19 Investment Highlights 0:34:42 20 Contact Info 0:35:53
- Question Period 21 Questions 0:35:56 22 DNA Complete? 0:36:01 23 DNA Complete Sales? 0:37:12 24 DNA Complete Launch? 0:38:07 25 BE-Smart Test? 0:40:51 26 Financing? 0:44:05 27 Profit Forecast? 0:44:51 28 BE-Smart Partnership? 0:51:41
- Final Remarks 29 Outro 0:56:38
0:00:00 | 0:59:12
Third Quarter 2024 Results Virtual Conference Call: NASDAQ - PRPH (ID 2448)
Subscribe
Open Interactive SlidelistSlidelist
